stock
Enliven Therapeutics Inc.
NASDAQ | ELVN
18.43
USD
$0.00
(0.00%
)At Close (As of Sep 16, 2025)
$1.10B
Market Cap
-
P/E Ratio
-1.99
EPS
$30.03
52 Week High
$13.30
52 Week Low
HEALTHCARE
Sector
ELVN Chart
Recent Chart
Price Action
ELVN Technicals
ELVN Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | -$317K |
| Total Revenue | $0 |
| Cost Of Revenue | $317K |
| Costof Goods And Services Sold | $317K |
| Operating Income | -$105M |
| Selling General And Administrative | $24M |
| Research And Development | $80M |
| Operating Expenses | $105M |
| Investment Income Net | - |
| Net Interest Income | $15M |
| Interest Income | $15M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $317K |
| Income Before Tax | -$89M |
| Income Tax Expense | -$232K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$89M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$89M |
| Ebitda | -$88M |
| Net Income | -$89M |
Revenue & Profitability
Earnings Performance
ELVN Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $326M |
| Total Current Assets | $318M |
| Cash And Cash Equivalents At Carrying Value | $124M |
| Cash And Short Term Investments | $124M |
| Inventory | - |
| Current Net Receivables | - |
| Total Non Current Assets | $7.6M |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | - |
| Intangible Assets Excluding Goodwill | - |
| Goodwill | - |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $189M |
| Other Current Assets | $4.7M |
| Other Non Current Assets | - |
| Total Liabilities | $16M |
| Total Current Liabilities | $16M |
| Current Accounts Payable | $1.3M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | - |
| Total Non Current Liabilities | $0 |
| Capital Lease Obligations | $0 |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | - |
| Other Current Liabilities | $15M |
| Other Non Current Liabilities | - |
| Total Shareholder Equity | $310M |
| Treasury Stock | - |
| Retained Earnings | -$243M |
| Common Stock | $49K |
| Common Stock Shares Outstanding | $47M |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$73M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $317K |
| Capital Expenditures | $44K |
| Change In Receivables | - |
| Change In Inventory | - |
| Profit Loss | - |
| Cashflow From Investment | -$36M |
| Cashflow From Financing | $133M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$89M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | -$317K |
| Total Revenue | $0 |
| Cost Of Revenue | $317K |
| Costof Goods And Services Sold | $317K |
| Operating Income | -$105M |
| Selling General And Administrative | $24M |
| Research And Development | $80M |
| Operating Expenses | $105M |
| Investment Income Net | - |
| Net Interest Income | $15M |
| Interest Income | $15M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $317K |
| Income Before Tax | -$89M |
| Income Tax Expense | -$232K |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$89M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$89M |
| Ebitda | -$88M |
| Net Income | -$89M |
ELVN News
ELVN Profile
Enliven Therapeutics Inc. Profile
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
None
ADAP +20.12%
$0.08
CODX +80.75%
$0.63
CGBS -39.47%
$0.03
MULN +9.26%
$0.07
TURB +359.25%
$12.40
BITF +15.32%
$2.86
NVDA -1.61%
$174.88
SNAP +3.11%
$7.69
NIO +8.24%
$7.02
APVO +4.16%
$1.50
MARA +7.94%
$17.53
KDLY -55.39%
$1.24
GRAB +2.85%
$6.31
AAL -0.95%
$12.41
TSLA +3.15%
$422.99
OPI -5.54%
$0.83
WBD -6.19%
$18.25
NAKA
+18.95%
$1.47
TPIC -45.91%
$0.12
PLUG +7.00%
$1.68
DNN -2.92%
$2.50
AXDX -61.36%
$0.03
SOFI -0.90%
$27.42
SOUN +3.52%
$14.69
SLNH +3.79%
$0.96
AAPL +0.61%
$238.15
NFE +44.92%
$2.00
RIVN +5.29%
$14.32
F -0.59%
$11.61
JOBY +1.77%
$14.37
NAOV +64.86%
$10.70
LYT -16.77%
$0.09
RIOT +5.03%
$17.52
BMNR
+5.31%
$55.93
CJET +0.43%
$0.11
RR -0.51%
$3.87
BTG -1.48%
$4.32
PFE -0.39%
$23.87
BGI +58.97%
$1.35
INTC +2.13%
$25.30
BINI
-15.62%
$0.06
ORCL +1.30%
$306.07
ATYR +6.40%
$1.08
RAYA -1.47%
$0.04
ATCH -13.06%
$0.86
RGTI +4.11%
$20.00
BOXL +45.66%
$2.52
ABEV +1.50%
$2.36
QS -2.17%
$10.13
CNFR +55.53%
$1.76
HIMS -5.35%
$51.07
RKLB -12.64%
$47.20
RMBL +60.50%
$3.21
BBD +0.78%
$3.20
DVLT +32.99%
$0.44
ADD -25.47%
$0.05
AMZN +1.13%
$234.05
TLRY +3.38%
$1.22
VALE +0.87%
$10.92
ONDS -4.54%
$6.09
WULF -2.50%
$10.49
HOOD +2.22%
$117.38
IREN -1.85%
$36.45
SRM +53.27%
$10.30
QBTS +3.68%
$18.99
KEY -1.14%
$18.62
GOOGL -0.17%
$251.16
ITUB +0.21%
$7.15
LPSN -22.92%
$0.68
CAN -1.22%
$0.80
BAC +0.19%
$50.69
NOK +1.20%
$4.60
IONQ +5.31%
$62.25
BTE -0.15%
$2.36
NWTN +3.42%
$1.51
AIIO
+3.42%
$1.51
PLTR -0.49%
$170.36
CUTR -10.19%
$0.09
PET -59.91%
$0.04
CLSK +8.84%
$11.20
ORIS -23.42%
$0.13
QUBT +0.20%
$16.87
CRWV
-1.42%
$118.75
WLGS -5.57%
$0.04
FAAS -23.86%
$0.09
CIFR +6.40%
$11.54
RZLV -0.79%
$7.65
AMD -0.43%
$160.46
RIG +4.98%
$3.47
ACHR -0.53%
$9.07
ETWO 0.00%
$3.30
OSCR -4.40%
$17.90
CVE +2.65%
$17.61
HBAN -1.13%
$17.43
BURU
-8.18%
$0.13
JD +3.15%
$34.68
LYFT -1.22%
$20.19
AMCR +1.50%
$8.40
BABA +2.68%
$162.29
GOOG -0.13%
$251.42
ADAP +20.12%
$0.08
CODX +80.75%
$0.63
CGBS -39.47%
$0.03
MULN +9.26%
$0.07
TURB +359.25%
$12.40
BITF +15.32%
$2.86
NVDA -1.61%
$174.88
SNAP +3.11%
$7.69
NIO +8.24%
$7.02
APVO +4.16%
$1.50
MARA +7.94%
$17.53
KDLY -55.39%
$1.24
GRAB +2.85%
$6.31
AAL -0.95%
$12.41
TSLA +3.15%
$422.99
OPI -5.54%
$0.83
WBD -6.19%
$18.25
NAKA
+18.95%
$1.47
TPIC -45.91%
$0.12
PLUG +7.00%
$1.68
DNN -2.92%
$2.50
AXDX -61.36%
$0.03
SOFI -0.90%
$27.42
SOUN +3.52%
$14.69
SLNH +3.79%
$0.96
AAPL +0.61%
$238.15
NFE +44.92%
$2.00
RIVN +5.29%
$14.32
F -0.59%
$11.61
JOBY +1.77%
$14.37
NAOV +64.86%
$10.70
LYT -16.77%
$0.09
RIOT +5.03%
$17.52
BMNR
+5.31%
$55.93
CJET +0.43%
$0.11
RR -0.51%
$3.87
BTG -1.48%
$4.32
PFE -0.39%
$23.87
BGI +58.97%
$1.35
INTC +2.13%
$25.30
BINI
-15.62%
$0.06
ORCL +1.30%
$306.07
ATYR +6.40%
$1.08
RAYA -1.47%
$0.04
ATCH -13.06%
$0.86
RGTI +4.11%
$20.00
BOXL +45.66%
$2.52
ABEV +1.50%
$2.36
QS -2.17%
$10.13
CNFR +55.53%
$1.76
HIMS -5.35%
$51.07
RKLB -12.64%
$47.20
RMBL +60.50%
$3.21
BBD +0.78%
$3.20
DVLT +32.99%
$0.44
ADD -25.47%
$0.05
AMZN +1.13%
$234.05
TLRY +3.38%
$1.22
VALE +0.87%
$10.92
ONDS -4.54%
$6.09
WULF -2.50%
$10.49
HOOD +2.22%
$117.38
IREN -1.85%
$36.45
SRM +53.27%
$10.30
QBTS +3.68%
$18.99
KEY -1.14%
$18.62
GOOGL -0.17%
$251.16
ITUB +0.21%
$7.15
LPSN -22.92%
$0.68
CAN -1.22%
$0.80
BAC +0.19%
$50.69
NOK +1.20%
$4.60
IONQ +5.31%
$62.25
BTE -0.15%
$2.36
NWTN +3.42%
$1.51
AIIO
+3.42%
$1.51
PLTR -0.49%
$170.36
CUTR -10.19%
$0.09
PET -59.91%
$0.04
CLSK +8.84%
$11.20
ORIS -23.42%
$0.13
QUBT +0.20%
$16.87
CRWV
-1.42%
$118.75
WLGS -5.57%
$0.04
FAAS -23.86%
$0.09
CIFR +6.40%
$11.54
RZLV -0.79%
$7.65
AMD -0.43%
$160.46
RIG +4.98%
$3.47
ACHR -0.53%
$9.07
ETWO 0.00%
$3.30
OSCR -4.40%
$17.90
CVE +2.65%
$17.61
HBAN -1.13%
$17.43
BURU
-8.18%
$0.13
JD +3.15%
$34.68
LYFT -1.22%
$20.19
AMCR +1.50%
$8.40
BABA +2.68%
$162.29
GOOG -0.13%
$251.42